1. Jemal A, Siegel R, Ward E, et al. Cancer statistics,. CA
Cancer J Clin. 2008;58(2):71-96.
2. Hewitt M, Weiner SL, Simone JVE. Childhood Cancer
Survivorship: Improving Care and Quality of Life. Washington,
DC: National Academies Press; 2003.
3. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health
conditions in adult survivors of childhood cancer. N Engl
J Med. 2006;355(15): 1572-1582.
4. Noorda EM, Somers R, van Leeuwen FE, Vulsma T, Behrendt H.
Dutch Late Effects Study Group. Adult height and age at menarche
in childhood cancer survivors.
Eur J Cancer. 2001;37:605-612.
[PubMed: 11290436]
5. Robison LL, Nesbit ME Jr., Sather HN, Meadows AT, Ortega JA,
Hammond GD. Height of children successfully treated for acute lymphoblastic
leukemia: a report from the Late Effects Study Committee of Children’s
Cancer Study Group. Med Pediatr Oncol. 1985;13(1):14-21.
6. Sklar C. Reproductive physiology and treatment-related loss
of sex hormone production.
Med Pediatr Oncol. 1999;33:2.
[PubMed: 10401490]
7. Sherins RJ, Olweny CLM, Ziegler JL. Gynecomastia and gonadal
dysfunction in adolescent boys treated with combination chemotherapy
for Hodgkin’s disease.
N Engl J Med. 1978;299:12.
[PubMed: 661845]
8. Hobbie WL, Ginsberg JP, Ogle SK, Carlson CA, Meadows AT. Fertility
in males treated for Hodgkins disease with COPP/ABV hybrid.
Pediatr
Blood Cancer. 2005;44:193-196.
[PubMed: 15390272]
9. Stillman RJ, Schinfeld JS, Schiff I, et al. Ovarian failure
in long-term survivors of childhood malignancy. Am J Obstet
Gynecol. 1981;139(1):62-66.
10. Ortin TTS, Shostak CA, Donaldson SS. Gonadal status and reproductive
function following treatment for Hodgkin’s disease in childhood:
the Stanford experience.
Int J Radiat Oncol Biol Phys. 1990;19:873.
[PubMed: 2211255]
11. Liesner RJ, Leiper AD, Hann IM, Chessells JM. Late effects
of intensive treatment for acute myeloid leukemia and myelodysplasia in
childhood.
J Clin Oncol. 1994;12:916-924.
[PubMed: 8164042]
12. Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after
bone marrow transplantation performed before menarche. Arch
Dis Child. 1999;80(5):452-454.
13. Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, Brauner
R. Factors affecting gonadal function after bone marrow transplantation
during childhood.
Bone Marrow Transplant. 2001;28:67-75.
[PubMed: 11498747]
14. Sanders JE, Buckner CD, Leonard JM, et al. Late effects
on gonadal function of cyclophosphamide, total-body irradiation,
and marrow transplantation. Transplantation. 1983;36(3):252-255.
15. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause
in survivors of childhood cancer: a report from the childhood cancer survivor
study. J Natl Cancer Inst. 2006;98(13):890-896.
16. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the
thyroid in survivors of Hodgkin’s disease: data from the
Childhood Cancer Survivor Study.
J Clin Endocrinol Metab. 2000;85:3227-3232.
[PubMed: 10999813]
17. Devney RB, Sklar CA, Nesbit ME Jr, et al. Serial thyroid
function measurements in children with Hodgkin disease. J
Pediatr. 1984;105(2):223-227.
18. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based
guidelines for pediatric cancer survivors: the Children’s Oncology
Group Long-Term Follow-Up Guidelines from the Children’s
Oncology Group Late Effects Committee and Nursing Discipline. J
Clin Oncol. 2004;22(24):4979-4990.
19. Moore BD III. Neurocognitive outcomes in survivors of childhood
cancer. J Pediatr Psychol. 2005;30(1):51-63.
20. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late
neurocognitive sequelae in survivors of brain tumours in childhood. Lancet
Oncol. 2004;5(7):399-408.
21. Mulhern RK, Reddick WE, Palmer SL, et al. Neurocognitive deficits
in medulloblastoma survivors and white matter loss. Ann
Neurol. 1999;46(6):834-841.
22. Mitby PA, Robison LL, Whitton JA, et al. Utilization of
special education services and educational attainment among long-term
survivors of childhood cancer: a report from the Childhood Cancer Survivor
Study. Cancer. 2003;97(4):1115-1126.
23. Nathan PC, Patel SK, Dilley K, et al. Guidelines for identification of,
advocacy for, and intervention in neurocognitive problems in survivors
of childhood cancer: a report from the Children’s Oncology Group. Arch
Pediatr Adolesc Med. 2007;161(8):798-806.
24. Grenier MA, Lipshultz SE. Epidemiology of anthracycline
cardiotoxicity in children and adults. Semin Oncol. 1998;25(4
suppl 10):S72-S85.
25. Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated
cardiotoxicity in survivors of childhood cancer. Heart. 2008;94(4):525-533.
26. Pein F, Sakiroglu O, Dahan M, et al. Cardiac abnormalities
15 years and more after adriamycin therapy in 229 childhood survivors of
a solid tumour at the Institut Gustave Roussy. Br J Cancer. 2004;91(1):37-44.
27. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz
SE. Radiation-associated cardiovascular disease. Crit Rev
Oncol Hematol. 2003;45(1):55-75.
28. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, van Putten
WL, Levendag PC. Ischemic heart disease after mantlefield irradiation
for Hodgkin’s disease in long-term follow-up. Radiother
Oncol. 1999;51(1):35-42.
29. Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular
disease in survivors of childhood cancer: report from the Cardiovascular
Disease Task Force of the Children’s Oncology Group. Pediatrics. 2008;121:e387-396
30. Carver JR, Ng A, Meadows AT, Vaughn DJ. Cardiovascular late
effects and the ongoing care of adult cancer survivors.
Dis
Management. 2008; 11:1-6.
[PubMed: 18279108]
31. Griese M, Rampf U, Hofmann D, Fuhrer M, Reinhardt D, Bender-Gotze
C. Pulmonary complications after bone marrow transplantation in
children: twenty-four years of experience in a single pediatric
center.
Pediatr Pulmonol. 2000;30:393-401.
[PubMed: 11064430]
32. Eigen H, Wyszomierski D.
Bleomycin lung injury in children: pathophysiology
and guidelines for management.
Am J Pediatr Hematol Oncol. 1985;7:71.
[PubMed: 2412460]
33. Schwerzmann M, Seiler C. Recreational scuba diving, patent foramen
ovale and their associated risks.
Swiss Med Wkly. 2001;131:365-374.
[PubMed: 11524902]
34. Elliott AJ, Oakhill A, Goodman S. Cataracts in childhood
leukaemia.
Br J Ophthalmol. 1985;69: 459-461.
[PubMed: 3859324]
35. Hoover DL, Smith LE, Turner SJ, et al. Ophthalmic evaluation
of survivors of acute lymphoblastic leukemia.
Ophthalmology. 1988;95:151-155.
[PubMed: 3173990]
36. Gurney JG, Ness KK, Rosenthal J, et al. Visual, auditory, sensory,
and motor impairments in long-term survivors of hematopoietic stem
cell transplantation performed in childhood: results from the Bone
Marrow Transplant Survivor Study.
Cancer. 2006;106:1402-1408.
[PubMed: 16453335]
37. Holmstrom G, Borgstrom B, Calissendorff B. Cataract in children
after bone marrow transplantation: relation to conditioning regimen.
Acta
Ophthalmol Scand. 2002;80:211-215.
[PubMed: 11952491]
38. Bray LC, Carey PJ, Proctor SJ, et al. Ocular complications
of bone marrow transplantation.
Br J Ophthalmol. 1991;75:611-614.
[PubMed: 1954211]
39. Leung W, Hudson M, Zhu Y, et al. Late effects in survivors
of infant leukemia.
Leukemia. 2000;
14:1185-1190.
[PubMed: 10914540]
40. Matz GJ. Aminoglycoside cochlear ototoxicity.
Otolaryngol
Clin North Am. 1993;26:705-712.
[PubMed: 8233484]
41. Nasman M, Forsberg CM, Dahllof G. Long-term dental development
in children after treatment for malignant disease.
Eur J
Orthod. 1997;19:151-159.
[PubMed: 9183064]
42. Uderzo C, Fraschini D, Balduzzi A, et al. Long-term effects
of bone marrow transplantation on dental status in children with
leukaemia.
Bone Marrow Transplant. 1997;20:865-869.
[PubMed: 9404928]
43. Dahllof G, Barr M, Bolme P, et al. Disturbances in dental
development after total body irradiation in bone marrow transplant
recipients.
Oral Surg Oral Med Oral Pathol. 1988;65:41-44.
[PubMed: 2963247]
44. Vora A, Mitchell CD, Lennard L, et al. Toxicity and efficacy
of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic
leukaemia: a randomised trial.
Lancet. 2006;368:1339-1348.
[PubMed: 17046466]
45. Cesaro S, Petris MG, Rossetti F, et al. Chronic hepatitis
C virus infection after treatment for pediatric malignancy.
Blood. 1997;90:1315-1320.
[PubMed: 9242567]
46. Strasser SI, Sullivan KM, Myerson D, et al. Cirrhosis of
the liver in long-term marrow transplant survivors.
Blood. 1999;93:3259-3266.
[PubMed: 10233877]
47. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance
imaging detection of avascular necrosis of the bone in children
receiving intensive prednisone therapy for acute lymphoblastic leukemia
or non-Hodgkin lymphoma.
Leukemia. 2001;15:891-897.
[PubMed: 11417473]
48. Socie G, Selimi F, Sedel L, et al. Avascular necrosis of
bone after allogeneic bone marrow transplantation: clinical findings, incidence
and risk factors.
Br J Haematol.1994;86:624-628.
[PubMed: 8043445]
49. Bizot P, Nizard R, Socie G, et al. Femoral head osteonecrosis
after bone marrow transplantation. Clin Orthop Relat Res. 1998:127-134.
50. Vassilopoulou-Sellin R, Brosnan P, Delpassand A, et al.
Osteopenia in young adult survivors of childhood cancer.
Med
Pediatr Oncol. 1999;32:272-278.
[PubMed: 10102021]
51. Sklar C, Boulad F, Small T, et al. Endocrine complications
of pediatric stem cell transplantation. Front Biosci. 2001;6:G17-22.
52. Kaste SC, Rai SN, Fleming K, et al. Changes in bone mineral density
in survivors of childhood acute lymphoblastic leukemia.
Pediatr
Blood Cancer. 2006;46:77-87.
[PubMed: 16106430]
53. Jarfelt M, Fors H, Lannering B, et al. Bone mineral density
and bone turnover in young adult survivors of childhood acute lymphoblastic
leukaemia.
Eur J Endocrinol. 2006;154:303-309.
[PubMed: 16452545]
54. Inskip PD, Ries LAG, Cohen RJ, Curtis RE. New malignancies following
childhood cancer. In: Curtis RE, Freedman DM, Ron E, et al, eds. New
Malignancies among Cancer Survivors: SEER Cancer Registries, 1973–2000. Bethesda,
MD: National Cancer Institute. NIH Publ. No. 05-5302 2006:465-482.
55. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant
neoplasms in five-year survivors of childhood cancer: childhood
cancer survivor study. J Natl Cancer Inst. 2001;93(8):618-629.
56. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and
other second neoplasms after childhood Hodgkin’s disease. N
Engl J Med. 1996;334(12):745-751.
57. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new
cancers after radiotherapy in long-term survivors of retinoblastoma: an
extended follow-up.
J Clin Oncol. 2005;23:2272-2279.
[PubMed: 15800318]
58. Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating
agents, and risk of bone cancer after childhood cancer. J
Natl Cancer Inst. 1996;88(5):270-278.
59. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer
after a first tumour in childhood (the Childhood Cancer Survivor
Study): a nested case-control study. Lancet. 2005;365(9476):2014-2023.
60. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of
the central nervous system in survivors of childhood cancer: a report
from the Childhood Cancer Survivor Study. J Natl Cancer
Inst. 2006;98(21):1528-1537.
61. de Vathaire F, Hawkins M, Campbell S, et al. Second malignant
neoplasms after a first cancer in childhood: temporal pattern of
risk according to type of treatment. Br J Cancer. 1999;79(11-12):1884-1893.
62. Bhatia S, Yasui Y, Robison LL, et al. High Risk of subsequent neoplasms
continues with extended follow-up of childhood Hodgkin’s
disease: report from the Late Effects Study Group. J Clin
Oncol. 2003;21(23):4386-4394.
63. Wong FL, Boice JD, Jr., Abramson DH, et al. Cancer incidence
after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278(15):1262-1267.
64. Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin
disease treated with radiation therapy with or without chemotherapy:
long-term risks and risk factors. Blood. 2002;100(6):1989-1996.
65. Diller L, Medeiros Nancarrow C, Shaffer K, et al. Breast
cancer screening in women previously treated for Hodgkin’s
disease: a prospective cohort study. J Clin Oncol. 2002;20(8):2085-2091.
66. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines
for breast screening with MRI as an adjunct to mammography. CA
Cancer J Clin. 2007;57(2):75-89.
67. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr., Li FP. Multiple
primary cancers in families with Li-Fraumeni syndrome. J
Natl Cancer Inst. 1998;90(8):606-611.
68. Stevens MC, Mahler H, Parkes S. The health status of adult
survivors of cancer in childhood.
Eur J Cancer. 1998;34:694-698.
[PubMed: 9713276]
69. Garre ML, Gandus S, Cesana B, et al. Health status of long-term
survivors after cancer in childhood. Results of an uni-institutional
study in Italy. Am J Pediatr Hematol Oncol. May
1994;16(2):143-152.
70. Oeffinger KC, Eshelman DA, Tomlinson GE, Buchanan GR, Foster
BM. Grading of late effects in young adult survivors of childhood
cancer followed in an ambulatory adult setting. Cancer. 2000;88(7):1687-1695.
71. Kadan-Lottick NS, Robison LL, Gurney JG, et al. Childhood
cancer survivors’ knowledge about their past diagnosis
and treatment: Childhood Cancer Survivor Study. JAMA. 2002;287(14):
1832-1839.
72. Oeffinger KC, Mertens AC, Hudson MM, et al. Health care
of young adult survivors of childhood cancer: a report from the
Childhood Cancer Survivor Study. Ann Fam Med. 2004;2(1):61-70.
73. Oeffinger KC. Longitudinal risk-based health care for adult survivors
of childhood cancer.
Curr Probl Cancer. 2003;27:143-167.
[PubMed: 12748583]
74. Oeffinger KC. Childhood cancer survivors and primary care
physicians. J Fam Pract. 2000;49(8): 689-690.
75. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer
survivors: future directions for clinical care and research. Pediatr
Blood Cancer. 2006;46(2):143-148.
76. Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM. Transition
to adult health care for adolescents and young adults with chronic
conditions: position paper of the Society for Adolescent Medicine. J
Adolesc Health. 2003;33(4):309-311.
77. Michaud PA, Suris JC, Viner R. The adolescent with a chronic condition.
Part II: healthcare provision. Arch Dis Child. 2004;89(10):943-949.
78. Ginsberg JP, Hobbie WL, Carlson CA, Meadows AT. Delivering
long-term follow-up care to pediatric cancer survivors: transitional
care issues. Pediatr Blood Cancer. 2006;46(2):169-173.
79. Oeffinger KC, Wallace WH. Barriers to follow-up care of
survivors in the United States and the United Kingdom. Pediatr
Blood Cancer. 2006;46(2):135-142.